An increasing number of chronic diseases with the increasing awareness of immunization is the major propelling factor for the growth of the global market. For instance, as per the WHO (World Health Organization) in 2019, the 182 countries reported 364,808 measles cases. Additionally, the technical advancement in the vaccines is another driving factor for the growth of the target market. Moreover, the rise in government and non- government funding in the R&D to develop the vaccines which are the boosting factor for the growth of the global market.Pediatric Vaccines Market has attained maturity, in terms of some of the disease segments (like polio), for some diseases the vaccines are not yet developed, so the market for vaccines is not yet getting mature.

Pediatric Vaccines Market was valued at US$ 3.5 Billion in 2024 and is projected to grow at a CAGR of 7.5% to reach US$ 7.2 Billion by 2034.

The report " Pediatric Vaccines Market, By Technology (Live Attenuated, Inactivated, Toxoid, Conjugate, and Other Technologies), By Vaccine Type (Monovalent, and Multivalent), By Application (Pneumococcal Disease, Influenza, Measles, Mumps, and Rubella (MMR) and Other Applications), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030. The global pediatric vaccines market is growing up to the US $ 2.5 billion in 2034.

Key Highlights:

• In 2018, GlaxoSmithKline PLC. signed an agreement with Novartis to secure full ownership of the consumer healthcare business.

Key Market Insights from the report:        

The market report has been segmented based on technology, vaccine type, application, and region.

• By technology, the pediatric vaccines market is segmented into live attenuated, inactivated, toxoid, conjugate, and other technologies
• By vaccine type, the market is bifurcated into monovalent, and multivalent
• By application, the target market is segmented into pneumococcal disease, influenza, measles, mumps, and rubella (MMR) and other applications
• By Region, the market in North America is projected to estimate for highest revenue share, followed by the Europe market. The Asia- Pacific region is dominating region in the pediatric vaccine market due to a rise in government funding for the vaccination and due to increasing population. The increasing awareness about vaccines in the Asia-Pacific region drives the growth of the global market.

Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Pediatric Vaccines Market, By Technology (Live Attenuated, Inactivated, Toxoid, Conjugate, and Other Technologies), By Vaccine Type (Monovalent, and Multivalent), By Application (Pneumococcal Disease, Influenza, Measles, Mumps, and Rubella (MMR) and Other Applications), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2034

The prominent player operating in the pediatric vaccines market includes GlaxoSmithKline PLC., Indian Immunologicals Limited, AstraZeneca, Merck & Co. Inc., Mitsubishi Tanabe Pharma Corporation, Johnson & Johnson, Pfizer Inc., Sanofi SA, and Seqirus (CSL Limited)

About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

To know more

Contact Us:

Sales

Prophecy Market Insights

 U.S.  1 860 531 2574

RoW: 917775049802

Email- sales@prophecymarketinsights.com

Website- www.prophecymarketinsights.com

Blog- www.prophecyjournals.com